Paul Tudor Jones’s Zimmer Biomet ZBH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-2,700
Closed -$244K 4384
2026
Q1
$244K Sell
2,700
-3,300
-55% -$303K ﹤0.01% 3260
2025
Q4
$540K Sell
6,000
-8,000
-57% -$759K ﹤0.01% 2684
2025
Q3
$1.38M Buy
14,000
+7,900
+130% +$783K ﹤0.01% 2047
2025
Q2
$556K Buy
6,100
+2,200
+56% +$213K ﹤0.01% 2533
2025
Q1
$441K Buy
3,900
+1,800
+86% +$193K ﹤0.01% 2353
2024
Q4
$222K Buy
+2,100
New +$225K ﹤0.01% 2774
2024
Q3
Sell
-2,400
Closed -$260K 3188
2024
Q2
$260K Buy
+2,400
New +$283K ﹤0.01% 2067
2023
Q3
Sell
-1,500
Closed -$218K 2956
2023
Q2
$218K Sell
1,500
-4,800
-76% -$652K ﹤0.01% 2181
2023
Q1
$815K Buy
+6,300
New +$791K 0.01% 1327

Other funds holding ZBH

Paul Tudor Jones's ZBH Position: Q2 2026 in Review

Paul Tudor Jones opened a new position in Zimmer Biomet (ZBH) in Q2 2026: 71,996 shares worth $6.2M. The stake represents 0.01% of the portfolio and ranks #1136 among its holdings. This is a return to the name: Paul Tudor Jones previously reported a position in ZBH as recently as Q4 2025.

Paul Tudor Jones first reported a position in ZBH in Q2 2013 and has held it in 37 quarters since. The position peaked at $55.1M in Q3 2016. 904 funds tracked by Wall St. Rank hold ZBH as of Q2 2026.

  • Paul Tudor Jones held 71,996 shares of Zimmer Biomet worth $6.2M as of Q2 2026.
  • Zimmer Biomet was a new Paul Tudor Jones position in Q2 2026.
  • Zimmer Biomet made up 0.01% of Paul Tudor Jones's portfolio in Q2 2026, its #1136 holding.
  • Paul Tudor Jones first reported a position in Zimmer Biomet in Q2 2013 and has held it in 37 quarters since.
  • Paul Tudor Jones's Zimmer Biomet position peaked at $55.1M in Q3 2016.
  • 904 funds tracked by Wall St. Rank held Zimmer Biomet as of Q2 2026.

Based on Tudor Investment Corp's 13F filing for Q2 2026, filed 14 Aug 2026.